Skip to content

ARA-290 user reports (43)

Glowing 10Positive 13Mixed 3Nothing 8Negative 4Bad reaction 2

43 reports

  • Ara-290 has helped my pain an almost unbelievable amount. I was starting to believe I might never regain somewhat normal function in my hands. For years my hands were limited in function due to severe neuropathic pain, I still have significant pain, but much more function

    • 25 likes
    GlowingInjection

    years of severe neuropathic pain in hands/arms; ME/CFS, MCAS

  • I have seen really great results. My neuropathy was very bad and it has improved significantly. I have tried almost everything and this was the most helpful by far. Whether it lasts I’ll have to see.

    • 6 points
    GlowingRecovery & healingInjectionabout 1 month

    severe peripheral neuropathy

  • I started ARA 290 23 days ago. I’m also taking NAD and GLOW. My neuropathy pain is gone.

    • 3 points
    GlowingRecovery & healingInjection23 days (planning 3-4 months)

    peripheral neuropathy; stacked with NAD+, GLOW and alpha-lipoic acid

  • I’m now 90% better than I was before these cycles and I’m confident it’s been ara290 and/or KPV. So much so I’m stocking up for the next 5/10 years.

    • 3 points
    GlowingRecovery & healingInjectionseveral cycles

    spinal stenosis nerve pain; stacked with KPV after earlier BPC-157/TB-500/GHK-Cu

  • ARA-290 at 8mg once per day allowed me to use my hands normally with no adaptive devices and greatly reduced need for pain aids. The pain is still noticable, esp with heavy use of arms, but reduced to the point it rarely impedes daily activities anymore.

    • 3 likes
    Glowing8 mg/dayInjection~1.5 years

    same user, longer-term update; started at 4 mg

  • And FYI ... my sciatica has almost completely subsided after finishing my cycle

    • 3 likes
    Glowing1 cycle (11 vials)

    sciatica

  • Ussualy sciatica last 2-3 months before It completly stops. From hospitalized to back to normal in a week is crazy.

    • 2 points
    GlowingRecovery & healing1-2 mg/dayInjectiontwo short courses of 1-2 weeks

    recurrent sciatica; second course stacked with BPC-157 and TB-500

  • ARA was 1mg 5 days a week for 6 months and every other day since then. My nerve pain had stopped at 2 months. I have long Covid, non length dependent small fibre neuropathy and microangiopathy.

    • 2 points
    GlowingRecovery & healing1 mg 5 days/week, then every other dayInjection8 months

    long COVID non-length-dependent small fibre neuropathy; stacked with KPV and thymosin alpha-1

  • Friday was the 1st day since my constant back pain started 15 mo ago that I could stand for longer than 15 seconds without pain beginning & increasing intensity.

    • 2 points
    GlowingRecovery & healing5 mg/week intranasal with GHK-CuNasal2022-2023

    stenosis/scoliosis nerve damage; with GHK-Cu

  • My feet and lower legs have been numb for about 10 years. I started using ARA-290 about a month ago. The feeling in my feet is signifantly returning. I am totally blown away about this.

    • 1 point
    GlowingRecovery & healingInjectionabout 1 month

    diabetic neuropathy

  • Definite benefit, although it took12 days for it to start working. Symptom sensitivity to blood glucose changes largely vanished.

    • 93 points
    PositiveRecovery & healing4 mg/day (8 mg/day last 2 days)Injection28 days

    idiopathic length-dependent small fibre neuropathy; labs unchanged

  • It was amazing! Feeling started to come back, and I was surprised by how aware I was of temperature too

    • 12 points
    PositiveRecovery & healingInjection4 days

    undiagnosed numbness/tingling in feet, suspected small fibre neuropathy

  • I’ve been on ARA-290 for three days and it’s been a really positive experience for me. 2 days at 4mg and 1 day at 8mg. The feeling of what I & my doc suspect is excitotoxicity is bothersome and still there, but the rest of my body feels more quiet and stable.

    • 8 likes
    Positive4-8 mg/day3 days

    long COVID, doctor-supervised; with Thymogen and TB4

  • Subject took a cycle of ARA-290. 4mg SubQ for 28 days. Within 10 days: - Numbness was gone from forehead

    • 5 points
    PositiveRecovery & healing4 mg/dayInjection28 days

    post-herpetic neuralgia after forehead shingles (written as "subject" per sub rules)

  • ARA290 is beneficial for me.

    • 5 likes
    Positive
  • I microdose ARA-290 at 580mcg-640mcg, 3x a week for MCAS symptoms. Together ARA-290+Thymulin+KPV have eliminated all MCAS symptoms for me.

    • 4 points
    PositiveImmune580-640 mcg 3x/weekInjection

    infection-driven MCAS; stacked with thymulin and KPV

  • Definitely helped me. Not permanent- neuropathy slowly crept back. Expensive AF.

    • 4 points
    PositiveRecovery & healing0.5 mg titrated to 4 mg/dayInjectiona few months, twice

    fluoroquinolone-induced neuropathy; second cycle with BPC-157/TB-500

  • I just had major foot surgery. 3 large incisions. I’ve been on BPC for quite some time. 3 days after my surgery I also started Cartalax. And, because there I nerves involved, I started ARA-290 for nerve repair. Amazing how much it’s healed in 12 days.

    • 3 likes
    PositiveRecovery & healing12 days

    post major foot surgery with nerve involvement; with BPC-157 and Cartalax

  • As far as the numbness and stinging goes, I've had dramatic improvements for those particular symptoms and the results seem to last a pretty long time.

    • 2 points
    PositiveRecovery & healingInjection2-4 week courses, three times

    systemic small fibre neuropathy with autonomic symptoms and twitching

  • It definitely helped with pain. We took it for three weeks . And the pain is slowly coming .

    • 1 point
    PositiveRecovery & healing2-4 mg/dayInjection3 weeks, then one week a month

    back-injury nerve damage (her) and diabetic neuropathy (husband)

  • Worked well. I can put on socks while standing now without falling over. My neuropathy is numbness caused my chemo 13 years ago.

    • 1 point
    PositiveRecovery & healingInjectionone round

    chemotherapy-induced numbness from 13 years earlier

  • Pretty good, it definitely reduced the neuropathy and the strength in my weaker leg improved pretty substantially.

    • 1 point
    PositiveRecovery & healing4 mg/dayInjection25 days

    thoracic disc herniations with myelopathy; on top of KLOW

  • I did it but only for a few weeks and I did notice a bit of difference for sure. Wouldn't say dramatic but would imagine running it longer would help.

    • 1 like
    Positivea few weeks

    lower back / disc nerve pain

  • It’s hard to say tbh. I might take it again I’ll let you know if I do. I think like a month of it gives prob 2 months of relief

    • 3 points
    MixedRecovery & healingInjectionabout a month, several times

    small fibre neuropathy with autonomic symptoms

  • lately I’ve been getting local injection reactions. It hasn’t reversed my SFN but when I miss it for a few weeks the pain comes back.

    • 1 point
    MixedRecovery & healingInjectionlong-term

    small fibre neuropathy

  • So I have tinnitus, and what was crazy was how it just turned it off, within 10 mins of the injection.

    • 1 point
    MixedRecovery & healingInjectionseveral doses

    tinnitus and widespread nerve pain; already on SS-31

  • I used 4mg /d for a few weeks with no change in my pain.

    • 12 points
    NothingRecovery & healing4 mg/dayInjectiona few weeks

    painful post-COVID neuropathy in the feet

  • 14 days into ARA 290 and zero relief. Losing my mind in pain.

    • 7 points
    NothingRecovery & healing4 mg/dayInjection14 days

    severe small fibre neuropathy, housebound

  • Day 32 ARA 290 injectable peptide for neuropathic pain. Not even a tiny bit of improvement

    • 5 likes
    NothingInjection32 days

    small fiber peripheral neuropathy in the feet; podiatrist

  • Personally I saw no benefit after 4 months of ARA 290, but everyone responds differently

    • 3 points
    NothingRecovery & healingInjection4 months

    small fibre neuropathy

  • Yes, 4mg nightly hasnt done much for me! I think its very very case specific

    • 3 likes
    Nothing4 mg nightly
  • I took it and got no relief as well. For nearly six weeks, took a break, and then for another month where I bumped up the dosage.

    • 2 points
    NothingRecovery & healingInjectionabout 6 weeks plus another month at a higher dose

    small fibre neuropathy

  • I used ARA-290 myself for about 5–6 months, including roughly 3 months at 8 mg daily, but unfortunately I didn’t notice any meaningful improvement in my autonomic symptoms.

    • 1 point
    NothingRecovery & healingup to 8 mg/dayInjection5-6 months (3 at 8 mg/day)

    small fibre neuropathy with dysautonomia

  • based on what I did I felt no benefits whatsoever from the ARA290. I also don’t think I will be trying it again.

    • 1 point
    NothingRecovery & healing2 mg/day, irregularInjection

    fibromyalgia

  • I started at .5 mg, then 1 mg, then 2 mg, 3 mg and finally 4 mg. The nerves in my feet flared very painfully beginning at 2 mg. I stopped today and the flare is a bit less.

    • 2 points
    NegativeRecovery & healing0.5 mg titrated to 4 mg/dayInjection5 days (later a 3-4 week course)

    Sjögren's / post-COVID neuropathy with allodynia

  • To be honest the day and day after I took it my symptoms clicked a notch up so I quit it. Also, I paid 225 for a vial that seemed to last 6 days.

    • 1 point
    NegativeRecovery & healingInjectiona few days

    neuropathy; bought through a neurophysiologist's office

  • I just started it 3 days ago - i'm having headaches every day with it - I normally never have headaches

    • 1 point
    NegativeRecovery & healing2 mg/dayInjection3 days

    neuropathy

  • Nope, none besides it leaves hige welts & bruising on my thighs.

    • 1 point
    NegativeRecovery & healing2-4 mg/dayInjection

    residual nerve pain after L5/S1 compression and back surgery

  • I just knew my feet hurt really bad and I needed to go get more help. Before that I’d have flare ups but they’d fluctuate. After the ARA-290 I had to go and get help.

    • 2 points
    Bad reactionRecovery & healingInjection28 days

    peripheral neuropathy

  • Started at 1mg/day subQx4 days. Stomach lining feels fried - a lot like Imuran. Stomach pain woke me up last 2 nights. Fatigue worse, muscles feel weaker/crampy - exertion is much harder. Foot & pudendal neuropathic pain unchanged. Gastroparesis improved.

    • 2 likes
    Bad reaction1 mg/dayInjection4 days

    neuro-Sjogren's, doctor-supported

  • Currently on ARA for my chronic nerve pain. Got mine from AmiPeps and it’s super affordable. So far, I’m dreading cycling of it. Stuff’s amazing!

    • 1 like
    Glowingvendor-adjacent

    chronic nerve pain; names the vendor and its price

  • I started on #wolverine for the pain in my hip and knees. #ARA290 for the neuropathy. ... Now the neuropathy is going to take a little longer but after my first round of shots I can feel the numbness subsiding.

    • 3 likes
    Positivevendor-adjacent

    genetic neuropathy; Wolverine stack credited for hip/knee pain, also on retatrutide

  • Yes, multiple disc issues, stenosis and DDD. It helps with radiating pain for sure. It takes time and you have to run a lot. I always keep a couple 30mg kits in the personal stash.

    • 0 likes
    Positivevendor-adjacent

    multiple disc issues, stenosis, degenerative disc disease

Research notes, not medical advice. Updated .

Sequence

The peptide's chain of amino acids from its start (the N-terminus) to its end, one bead and one letter for each: A alanine, C cysteine, D aspartic acid, E glutamic acid, F phenylalanine, G glycine, H histidine, I isoleucine, K lysine, L leucine, M methionine, N asparagine, P proline, Q glutamine, R arginine, S serine, T threonine, V valine, W tryptophan, Y tyrosine. A modification such as an N-acetyl cap or a C-terminal amide changes how long it lasts in the body. Length tells related peptides apart, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4, and predicts neither effect nor safety.

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Peptides rank by this figure, those with no graded report yet after those with one, and Avoid ones after every other entry.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks after every peptide with graded reports until its own arrive.

Safety tier

Each peptide is tiered Clean, Caution or Avoid from its five risk axes under the chosen safety bar. An Avoid peptide carries a real risk of harm, a plausible route to serious harm rather than mere unpleasantness, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to rate a peptide Avoid. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin; taken by mouth or in the nose, a pack avoids the injection risks.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. The shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Shop trust

Each shop's trust on a 1–5 scale, read from its testing and its reputation: 1 for serious red flags (fabricated COAs, scam reports, impersonation, a closed shop), 2 for no public testing, a new shop or active complaints such as seized parcels, 3 for its own COAs or a short track record, 4 for verified third-party testing or a strong reputation, and 5 for third-party batch reports that name the shop, with years of good independent reputation. A shop without a score counts third-party batch testing as 4, its own COAs as 3 and no public tests as 2.

Best value

Within a category or a goal, a peptide that no other beats on both counts: none is rated more positively for the same or a lower monthly price, and none costs less for the same or a higher rating. The chart joins these into the best-value line; the cheapest of them and the best-rated of them both make it, so the line spans the trade-off from cheap to best. Avoid entries never count, and a peptide needs both a % positive and a price to be compared.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.